Rational Advisors’s West Pharmaceutical WST Stock Holding History

Rational Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.97K	Sell	25 -25	-50%	-$7.64K	﹤0.01%	184
2026 Q1	$13.1K	Buy	50 +25	+100%	+$6.22K	﹤0.01%	159
2025 Q4	$6.88K	Buy	25 +3	+14%	+$821	﹤0.01%	180
2025 Q3	$5.77K	Sell	22 -14	-39%	-$3.4K	﹤0.01%	189
2025 Q2	$7.88K	Buy	+36	New	+$7.7K	﹤0.01%	188
2023 Q4	–	Sell	-22	Closed	-$8.41K	–	280
2023 Q3	$8.41K	Hold	22	–	–	﹤0.01%	234
2023 Q2	$8.41K	Hold	22	–	–	﹤0.01%	223
2023 Q1	$7.62K	Hold	22	–	–	﹤0.01%	223
2022 Q4	$5.18K	Hold	22	–	–	﹤0.01%	220
2022 Q3	$5K	Buy	22 +1	+5%	+$305	﹤0.01%	232
2022 Q2	$6K	Buy	21 +1	+5%	+$325	﹤0.01%	226
2022 Q1	$8K	Buy	+20	New	+$7.83K	﹤0.01%	230
2015 Q3	$115K	Hold	2,116	–	–	0.05%	201
2015 Q2	$123K	Sell	2,116 -264	-11%	-$14.7K	0.04%	201
2015 Q1	$143K	Buy	2,380 +980	+70%	+$52.2K	0.03%	206
2014 Q4	$75K	Buy	+1,400	New	+$70K	0.01%	283
2013 Q4	–	Sell	-2,080	Closed	-$171K	–	883
2013 Q3	$171K	Hold	2,080	–	–	0.01%	536
2013 Q2	$73K	Buy	+2,080	New	+$68.5K	0.01%	696

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Rational Advisors's WST Position: Q2 2026 in Review

Rational Advisors reduced its West Pharmaceutical (WST) stake by 50% in Q2 2026, selling an estimated $7.64K and leaving 25 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #184.

Rational Advisors first reported a position in WST in Q2 2013 and has held it in 18 quarters since. The position peaked at $171K in Q3 2013. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Rational Advisors held 25 shares of West Pharmaceutical worth $8.97K as of Q2 2026.
Rational Advisors sold 25 West Pharmaceutical shares in Q2 2026, an estimated $7.64K.
West Pharmaceutical made up ﹤0.01% of Rational Advisors's portfolio in Q2 2026, its #184 holding.
Rational Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 18 quarters since.
Rational Advisors's West Pharmaceutical position peaked at $171K in Q3 2013.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Rational Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.